Adaptive Biotechnologies Corp develops immune medicine products by decoding the adaptive immune system using proprietary next-generation sequencing (NGS), computational biology, and machine learning. Its MRD business offers clonoSEQ, the first FDA-authorized test for minimal residual disease detection in multiple myeloma, ALL, and CLL. Its Immune Medicine business sequences and maps T-cell receptors (TCRs) and B-cell receptors (BCRs) to disease antigens, serving biopharmaceutical partners, researchers, and clinicians across oncology and autoimmunity.
Q2 FY2026 — expected 2026-08-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076902 | EDGAR | 86K words |
| 2025-03-03 | 2024-12-31 | 0000950170-25-030913 | EDGAR | 90K words |
| 2024-02-29 | 2023-12-31 | 0000950170-24-023095 | EDGAR | 87K words |
| 2023-02-14 | 2022-12-31 | 0000950170-23-002792 | EDGAR | 97K words |
| 2022-02-15 | 2021-12-31 | 0001564590-22-005228 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001564590-21-008124 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0001564590-20-006830 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001193125-26-332940 | EDGAR | 29K words |
| 2025-11-05 | 2025-09-30 | 0001193125-25-267061 | EDGAR | 28K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103120 | EDGAR | 27K words |
| 2025-05-01 | 2025-03-31 | 0000950170-25-061897 | EDGAR | 23K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123423 | EDGAR | 29K words |
| 2024-08-01 | 2024-06-30 | 0000950170-24-089342 | EDGAR | 29K words |
| 2024-05-07 | 2024-03-31 | 0000950170-24-054604 | EDGAR | 25K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062136 | EDGAR | 26K words |
| 2023-08-02 | 2023-06-30 | 0000950170-23-037234 | EDGAR | 25K words |
| 2023-05-03 | 2023-03-31 | 0000950170-23-017250 | EDGAR | 21K words |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021923 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001564590-22-027784 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-29 | 0001193125-26-323753 | EDGAR | 4K words |
| 2026-02-05 | 0001193125-26-039409 | EDGAR | 4K words |
| 2026-01-12 | 0001193125-26-009840 | EDGAR | 2K words |
| 2025-12-30 | 0001193125-25-335921 | EDGAR | 1K words |
| 2025-11-05 | 0001193125-25-266974 | EDGAR | 4K words |
| 2025-08-18 | 0001193125-25-182222 | EDGAR | 1K words |
| 2025-08-05 | 0000950170-25-103058 | EDGAR | 4K words |
| 2025-06-12 | 0001193125-25-140017 | EDGAR | 1K words |
| 2025-05-01 | 0000950170-25-061851 | EDGAR | 4K words |
| 2025-02-11 | 0000950170-25-017915 | EDGAR | 5K words |
109 total filings indexed. 80 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001478320 |
| Ticker | ADPT |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | WA |
| Website | https://www.adaptivebiotech.com |
| Listed | 2019-06-27 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ADPT (~200 tokens, structured JSON with cryptographic provenance)